(Q54705108)

3 June 2018

title

Cinacalcet attenuates the renal endothelial-to-mesenchymal transition in rats with adenine-induced renal failure. (English)

1 reference

3 June 2018

0 references

Min Wu

1

1 reference

3 June 2018

Ri-Ning Tang

2

1 reference

3 June 2018

Hong Liu

3

1 reference

3 June 2018

Min Xu

4

1 reference

3 June 2018

Ming-Ming Pan

5

1 reference

3 June 2018

Bi-Cheng Liu

6

1 reference

3 June 2018

publication date

23 October 2013

1 reference

3 June 2018

American Journal of Physiology - Renal Physiology

published in

1 reference

3 June 2018

volume

306

1 reference

3 June 2018

issue

1

1 reference

3 June 2018

page(s)

F138-46

1 reference

3 June 2018

Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Parathyroid hormone accelerates decompensation following left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Cinacalcet improves endothelial dysfunction and cardiac hypertrophy in patients on hemodialysis with secondary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Parathyroid hormone-potentiated connective tissue growth factor expression in human renal proximal tubular cells through activating the MAPK and NF-kappaB signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Inflammatory stress exacerbates the progression of cardiac fibrosis in high-fat-fed apolipoprotein E knockout mice via endothelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Effects of angiotensin II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00375.2013

10.1152/AJPRENAL.00375.2013

21 January 2018

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

24154694

1 reference

3 June 2018